Inhibition of Plasmodium liver infection by ivermectin

Citations of this article
Mendeley users who have this article in their library.


Avermectins are powerful endectocides with an established potential to reduce the incidence of vector-borne diseases. Here, we show that several avermectins inhibit the hepatic stage of Plasmodium infection in vitro. Notably, ivermectin potently inhibits liver infection in vivo by impairing parasite development inside hepatocytes. This impairment has a clear impact on the ensuing blood stage parasitemia, reducing disease severity and enhancing host survival. Ivermectin has been proposed as a tool to control malaria transmission because of its effects on the mosquito vector. Our study extends the effect of ivermectin to the early stages of mammalian host infection and supports the inclusion of this multipurpose drug in malaria control strategies.




Mendes, A. M., Albuquerque, I. S., Machado, M., Pissarra, J., Meireles, P., & Prudêncio, M. (2017). Inhibition of Plasmodium liver infection by ivermectin. Antimicrobial Agents and Chemotherapy, 61(2).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free